Challenges and Future Opportunities for Transcatheter Aortic Valve Therapy

Progress in Cardiovascular Diseases

Volumn 56, Issue 6, 2014, Pages 635-645

  Leon, Martin B ^a   Gada, Hemal ^a   Fontana, Gregory P ^b  

^a NewYork Presbyterian Hospital   (United States)

^b LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

Aortic stenosis; Aortic valve replacement; Transcatheter aortic valve replacement

Indexed keywords

AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; AORTIC VALVE REPAIR; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; DISEASE SEVERITY; EMBOLIC PROTECTION DEVICE; FRAILTY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VALVE BIOPROSTHESIS; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; MEDICAL EDUCATION; PATIENT CARE; PATIENT SELECTION; PROSTHETIC VALVE DYSFUNCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT INDICATION; TREATMENT OUTCOME; VASCULAR ACCESS; WEAKNESS;

AORTIC STENOSIS; AORTIC VALVE REPLACEMENT; TRANSCATHETER AORTIC VALVE REPLACEMENT;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; DIFFUSION OF INNOVATION; FORECASTING; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT SELECTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84900020715     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2014.03.004     Document Type: Article

References (60)

1. Leon M.B., Smith C.R., Mack M., Miller D.C., Moses J.W., Svensson L.G., et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010, 363(17):1597-1607.
2. Mack M.J., Holmes D.R., Webb J., Cribier A., Kodali S.K., Williams M.R., et al. Patient selection for transcatheter aortic valve replacement. J Am Coll Cardiol 2013, 62(Suppl 17):S1-S10.
3. Afilalo J., Eisenberg M.J., Morin J.F., Bergman H., Monette J., Noiseux N., et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol 2010, 56(20):1668-1676.
4. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C., Gottdiener J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56(3):M146-M156.
5. Green P., Woglom A.E., Genereux P., Daneault B., Paradis J.M., Schnell S., et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. JACC Cardiovasc Interv 2012, 5(9):974-981.
6. Popma J.J., CoreValve U.S. Pivotal Trial Extreme Risk Iliofemoral Study Results 2013, Transcatheter Cardiovascular Therapeutics, San Francisco, CA.
7. Leon M.B. A Randomized Evaluation of the SAPIEN XT Transcatheter Valve System in Patients with Aortic Stenosis Who Are Not Candidates for Surgery: PARTNER II, Inoperable Cohort 2013, American College of Cardiology, San Francisco, CA.
8. Gaasch W.H., D'Agostino R.S. Transcatheter aortic valve implantation: The transfemoral versus the transapical approach. Ann Cardiothorac Surg 2012, 1(12):200-205.
9. van der Boon R.M., Marcheix B., Tchetche D., Chieffo A., Van Mieghem N.M., Dumonteil N., et al. Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study. Ann Thorac Surg 2014, 97(1):22-28.
10. Al Kindi A.H., Salhab K.F., Roselli E.E., Kapadia S., Tuzcu E.M., Svensson L.G. Alternative access options for transcatheter aortic valve replacement in patients with no conventional access and chest pathology. J Thorac Cardiovasc Surg 2014, 147(2):644-651.
11. Zierer A., Wimmer-Greinecker G., Martens S., Moritz A., Doss M. The transapical approach for aortic valve implantation. J Thorac Cardiovasc Surg 2008, 136(4):948-953.
12. Lardizabal J.A., O'Neill B.P., Desai H.V., Macon C.J., Rodriguez A.P., Martinez C.A., et al. The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States. J Am Coll Cardiol 2013, 61(23):2341-2345.
13. Cohen M.G., Singh V., Martinez C.A., O'Neill B.P., Alfonso C.E., Martinezclark P.O., et al. Transseptal antegrade transcatheter aortic valve replacement for patients with no other access approach - A contemporary experience. Catheter Cardiovasc Interv 2013, 82(6):987-993.
14. Modine T., Sudre A., Amr G., Delhaye C., Koussa M. Implantation of a Sapien XT Aortic Bioprosthesis through the Left Carotid Artery. J Card Surg 2014, (Epub ahead of print).
15. Bloomfield G.S., Gillam L.D., Hahn R.T., Kapadia S., Leipsic J., Lerakis S., et al. A practical guide to multimodality imaging of transcatheter aortic valve replacement. JACC Cardiovasc Imaging 2012, 5(4):441-455.
16. Holmes D.R., Mack M.J., Kaul S., Agnihotri A., Alexander K.P., Bailey S.R., et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 2012, 59(13):1200-1254.
17. Hahn R.T. Use of imaging for procedural guidance during transcatheter aortic valve replacement. Curr Opin Cardiol 2013, 28(5):512-517.
18. Grube E., Naber C., Abizaid A., Sousa E., Mendiz O., Lemos P., et al. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc Interv 2011, 4(7):751-757.
19. Garcia E., Martin P., Hernandez R., Rodriguez V., Fernandez A., Gama V., et al. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve. Catheter Cardiovasc Interv 2013, (Epub ahead of print).
20. Kodali S.K., Williams M.R., Smith C.R., Svensson L.G., Webb J.G., Makkar R.R., et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012, 366(18):1686-1695.
21. Ussia G.P., Barbanti M., Imme S., Scarabelli M., Mule M., Cammalleri V., et al. Management of implant failure during transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010, 76(3):440-449.
22. Nombela-Franco L., Rodes-Cabau J., DeLarochelliere R., Larose E., Doyle D., Villeneuve J., et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv 2012, 5(5):499-512.
23. Barbanti M., Yang T.H., Rodes Cabau J., Tamburino C., Wood D.A., Jilaihawi H., et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation 2013, 128(3):244-253.
24. Fairbairn T.A., Mather A.N., Bijsterveld P., Worthy G., Currie S., Goddard A.J., et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 2012, 98(1):18-23.
25. Kahlert P., Knipp S.C., Schlamann M., Thielmann M., Al-Rashid F., Weber M., et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010, 121(7):870-878.
26. Rodes-Cabau J., Dumont E., Boone R.H., Larose E., Bagur R., Gurvitch R., et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol 2011, 57(1):18-28.
27. Van Mieghem N.M., Schipper M.E., Ladich E., Faqiri E., van der Boon R., Randjgari A., et al. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation 2013, 127(22):2194-2201.
28. Eggebrecht H., Schmermund A., Voigtlander T., Kahlert P., Erbel R., Mehta R.H. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 2012, 8(1):129-138.
29. Moat N.E., Ludman P., de Belder M.A., Bridgewater B., Cunningham A.D., Young C.P., et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011, 58(20):2130-2138.
30. Sinning J.M., Hammerstingl C., Vasa-Nicotera M., Adenauer V., Lema Cachiguango S.J., Scheer A.C., et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol 2012, 59(13):1134-1141.
31. Tamburino C., Capodanno D., Ramondo A., Petronio A.S., Ettori F., Santoro G., et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011, 123(3):299-308.
32. Genereux P., Head S.J., Hahn R., Daneault B., Kodali S., Williams M.R., et al. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature. J Am Coll Cardiol 2013, 61(11):1125-1136.
33. Genereux P., Webb J.G., Svensson L.G., Kodali S.K., Satler L.F., Fearon W.F., et al. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol 2012, 60(12):1043-1052.
34. Genereux P., Cohen D.J., Williams M.R., Mack M., Kodali S.K., Svensson L., et al. Bleeding Complications after Surgical Aortic Valve Replacement (SAVR) Compared with Transcatheter Aortic Valve Replacement (TAVR): Insights from the PARTNER I Trial. J Am Coll Cardiol 2013.
35. Hayashida K., Lefevre T., Chevalier B., Hovasse T., Romano M., Garot P., et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 2011, 4(8):851-858.
36. Genereux P., Kodali S., Leon M.B., Smith C.R., Ben-Gal Y., Kirtane A.J., et al. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation. JACC Cardiovasc Interv 2011, 4(8):861-867.
37. Erkapic D., De Rosa S., Kelava A., Lehmann R., Fichtlscherer S., Hohnloser S.H. Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol 2012, 23(4):391-397.
38. Nazif T.M., Williams M.R., Hahn R.T., Kapadia S., Babaliaros V., Rodes-Cabau J., et al. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience. Eur Heart J 2013, [Epub ahead of print].
39. Houthuizen P., Van Garsse L.A., Poels T.T., de Jaegere P., van der Boon R.M., Swinkels B.M., et al. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation 2012, 126(6):720-728.
40. Tommaso C.L., Bolman R.M., Feldman T., Bavaria J., Acker M.A., Aldea G., et al. Multisociety (AATS, ACCF, SCAI, and STS) expert consensus statement: operator and institutional requirements for transcatheter valve repair and replacement, part 1: transcatheter aortic valve replacement. J Am Coll Cardiol 2012, 59(22):2028-2042.
41. Stolker J.M., Patel A.Y., Lim M.J., Hauptman P.J. Estimating the Adoption of Transcatheter Aortic Valve Replacement By US Interventional Cardiologists and Clinical Trialists. Clin Cardiol 2013, 36(11):691-697.
42. Webb J.G., Wood D.A., Ye J., Gurvitch R., Masson J.B., Rodes-Cabau J., et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation 2010, 121(16):1848-1857.
43. Wenaweser P., Buellesfeld L., Gerckens U., Grube E. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system. Catheter Cardiovasc Interv 2007, 70(5):760-764.
44. Bapat V.N., Attia R., Thomas M. Effect of Valve Design on the Stent Internal Diameter of a Bioprosthetic Valve: A Concept of True Internal Diameter and Its Implications for the Valve-in-Valve Procedure. JACC Cardiovasc Interv 2014, 7(2):115-127.
45. Dvir D., Webb J., Brecker S., Bleiziffer S., Hildick-Smith D., Colombo A., et al. Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry. Circulation 2012, 126(19):2335-2344.
46. Latib A., Maisano F., Bertoldi L., Giacomini A., Shannon J., Cioni M., et al. Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: a propensity score-matched case-control study. Am Heart J 2012, 164(6):910-917.
47. Herrmann H.C., Pibarot P., Hueter I., Gertz Z.M., Stewart W.J., Kapadia S., et al. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis. Circulation 2013, 127(3):2316-2326.
48. Chandola R., Cusimano R., Osten M., Horlick E. Postcardiac transplant transcatheter core valve implantation for aortic insufficiency secondary to Impella device placement. Ann Thorac Surg 2012, 93(6):e155-e157.
49. Dumonteil N., Marcheix B., Lairez O., Laborde J.C. Transcatheter aortic valve implantation for severe, non-calcified aortic regurgitation and narrow aortic root: description from a case report of a new approach to potentially avoid coronary artery obstruction. Catheter Cardiovasc Interv 2013, 82(2):E124-E127.
50. Windecker S. One-year outcomes from the SOURCE XT post-approval study 2013, EuroPCR, Paris, France.
51. Binder R.K., Rodes-Cabau J., Wood D.A., Mok M., Leipsic J., De Larochelliere R., et al. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv 2013, 6(3):293-300.
52. Ribeiro H.B., Urena M., Kuck K.H., Webb J.G., Rodes-Cabau J. Edwards CENTERA valve. EuroIntervention 2012, 8(Suppl. Q):Q79-Q82.
53. Sinning J.M., Werner N., Nickenig G., Grube E. Medtronic CoreValve Evolut valve. EuroIntervention 2012, 8(Suppl. Q):Q94-Q96.
54. Holzhey D., Linke A., Treede H., Baldus S., Bleiziffer S., Wagner A., et al. Intermediate follow-up results from the multicenter engager European pivotal trial. Ann Thorac Surg 2013, 96(6):2095-2100.
55. Urena M., Doyle D., Rodes-Cabau J., Dumont E. Initial experience of transcatheter aortic valve replacement with the St Jude Medical Portico valve inserted through the transapical approach. J Thorac Cardiovasc Surg 2013, 146(4):e24-e27.
56. Kempfert J., Treede H., Rastan A.J., Schonburg M., Thielmann M., Sorg S., et al. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA): 6-month outcomes. Eur J Cardiothorac Surg 2013, 43(1):52-56. [discussion 57].
57. Mollmann H., Diemert P., Grube E., Baldus S., Kempfert J., Abizaid A. Symetis ACURATE TF aortic bioprosthesis. EuroIntervention 2013, 9:S107-S110. [Suppl].
58. Schofer J., Colombo A., Klugmann S., Fajadet J., Demarco F., Tchetche D., et al. Prospective Multicenter Evaluation of the Direct Flow Medical(R) Transcatheter Aortic Valve. J Am Coll Cardiol 2013, 63(8):763-768.
59. Seiffert M., Diemert P., Koschyk D., Schirmer J., Conradi L., Schnabel R., et al. Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation. JACC Cardiovasc Interv 2013, 6(6):590-597.
60. Tofield A. The Lotus valve for transcatheter aortic valve implantation. Eur Heart J 2013, 34(30):2335.